X

Cannabis

GW Pharmaceuticals stock jumps 20% on Epidiolex strength

GW Pharmaceuticals (NASDAQ: GWPH) reported third-quarter 2020 financial results before the regular trading hours on Tuesday. The company, which specializes…

HEXO Corp (HEXO) Earnings: 4Q20 Key Numbers

HEXO Corp (NYSE: HEXO) reported net revenue of CAD27.1 million for the fourth quarter of 2020, reflecting an increase of…

Aphria Inc. (APHA) Q1 2021 Earnings Call Transcript

Aphria Inc.  (NYSE: APHA) Q1 2021 earnings call dated Oct. 15, 2020 Corporate Participants: Tamara Macgregor -- Chief Corporate Affairs Officer Irwin…

Aurora Cannabis (ACB) banks on premium brands after disastrous Q4

Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report…

Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease…

During tough times, Tilray (TLRY) looks overseas to achieve growth targets

Cannabis was recognized as an essential business in several markets when the shutdown came into effect, including Canada and some…

GW Pharmaceuticals PLC (GWPH) Q2 2020 Earnings Call Transcript

GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz -- Vice President of Investor…

Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges

After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market…

Tilray Q2 loss widens despite revenue growth; results miss

https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite…

Canopy Growth (CGC) Q1 2021 earnings in a nutshell

Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase…